African Pharmaceutical Review.

African Pharmaceutical Review.

Disrupting and accelerating drug discovery for faster and more accurate lead identification

Disrupting and accelerating drug discovery for faster and more accurate lead identification


Download


According to Fujitsu, Research and development (R&D) spending continues to increase exponentially, set to reach forecasted levels of $200 billion per year by 2024. The discovery of new therapeutic drugs is a slow, laborious and costly process taking many years to develop new treatments. From target identification to launching a new treatment in the market takes 12-15 years per drug.
This is impacting the industry, the medical profession and the health of millions of people across the world. The need for industry disruption was clear and critical before the current pandemic and is even more so now. The question is how?

img
Writer

Bevin Likuyani

Bevin Likuyani is a pharmacist with a Master of Pharmacy in Pharmacoepidemiology and Pharmacovigilance and an MBA from the School of Business, University of Nairobi. He is also a Certified Supply Chain Professional (CSCP) from the American (Association of Supply Chain Management).